Bornika Roy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bornika Roy has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Anukriti Khare
1 shared publicationJennifer Thomas
1 shared publicationRahul Sharma
1 shared publicationRajendra Phartyal
1 shared publicationRakesh Kumar
1 shared publicationRishi Kodwani
1 shared publication
Latest Publications
- 1 April 2022
- Published by Elsevier in Seminars in Cell & Developmental Biology
- Vol. 124, 134-144
Therapeutic strategies for miRNA delivery to reduce hepatocellular carcinoma
- 1 April 2022
- Published by Elsevier in Seminars in Cell & Developmental Biology
- Vol. 124, 134-144
Therapeutic strategies for miRNA delivery to reduce hepatocellular carcinoma
- 17 November 2015
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 16 (2) , 200-211
A Review on Mechanisms of Anti Tumor Activity of Chalcones
Chalcones comprise a characteristic framework of 1, 3-diaryl-2-propen-1-one. They have been heralded as promising anti cancer drugs and have received much attention in the field of cancer research and drug development. The cytotoxicity of these potent pharmacophores is attributable to a wide spectrum of biological activities like anti inflammatory, anti proliferative, anti fungal, etc. These anti tumor activities are effectuated through apoptosis, cell cycle arrest, anti tubulin and so forth. This review summarizes the recent developments on anti tumor activity of synthetic and natural chalcones and their detailed underlying mechanisms as reported in the past.
- 17 November 2015
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 16 (2) , 200-211
A Review on Mechanisms of Anti Tumor Activity of Chalcones
Chalcones comprise a characteristic framework of 1, 3-diaryl-2-propen-1-one. They have been heralded as promising anti cancer drugs and have received much attention in the field of cancer research and drug development. The cytotoxicity of these potent pharmacophores is attributable to a wide spectrum of biological activities like anti inflammatory, anti proliferative, anti fungal, etc. These anti tumor activities are effectuated through apoptosis, cell cycle arrest, anti tubulin and so forth. This review summarizes the recent developments on anti tumor activity of synthetic and natural chalcones and their detailed underlying mechanisms as reported in the past.